Rank | Gene Set | Z-score |
---|---|---|
1 | protoporphyrinogen IX metabolic process (GO:0046501) | 8.69606880 |
2 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 8.31906796 |
3 | heme biosynthetic process (GO:0006783) | 6.77077272 |
4 | negative regulation of fibrinolysis (GO:0051918) | 6.74936092 |
5 | regulation of fibrinolysis (GO:0051917) | 6.59894000 |
6 | porphyrin-containing compound biosynthetic process (GO:0006779) | 6.31090017 |
7 | regulation of protein activation cascade (GO:2000257) | 6.13602161 |
8 | protein carboxylation (GO:0018214) | 6.06511890 |
9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.06511890 |
10 | complement activation, alternative pathway (GO:0006957) | 6.00800182 |
11 | L-phenylalanine catabolic process (GO:0006559) | 5.83064931 |
12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.83064931 |
13 | regulation of complement activation (GO:0030449) | 5.81135795 |
14 | glyoxylate metabolic process (GO:0046487) | 5.69096047 |
15 | tetrapyrrole biosynthetic process (GO:0033014) | 5.65224769 |
16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.54342894 |
17 | L-phenylalanine metabolic process (GO:0006558) | 5.54342894 |
18 | heme metabolic process (GO:0042168) | 5.42954180 |
19 | ribosomal small subunit assembly (GO:0000028) | 5.36804657 |
20 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.28048364 |
21 | telomere maintenance via semi-conservative replication (GO:0032201) | 5.18355565 |
22 | urea metabolic process (GO:0019627) | 5.11263379 |
23 | porphyrin-containing compound metabolic process (GO:0006778) | 5.10454753 |
24 | DNA strand elongation (GO:0022616) | 5.05673228 |
25 | blood coagulation, intrinsic pathway (GO:0007597) | 5.00181701 |
26 | DNA replication initiation (GO:0006270) | 4.96038272 |
27 | regulation of plasminogen activation (GO:0010755) | 4.87533495 |
28 | erythrocyte maturation (GO:0043249) | 4.86955611 |
29 | urea cycle (GO:0000050) | 4.82599041 |
30 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.81965466 |
31 | negative regulation of sterol transport (GO:0032372) | 4.75975290 |
32 | negative regulation of cholesterol transport (GO:0032375) | 4.75975290 |
33 | intestinal cholesterol absorption (GO:0030299) | 4.75262456 |
34 | DNA unwinding involved in DNA replication (GO:0006268) | 4.74757037 |
35 | regulation of cholesterol esterification (GO:0010872) | 4.70990036 |
36 | fibrinolysis (GO:0042730) | 4.65216981 |
37 | proline metabolic process (GO:0006560) | 4.64810609 |
38 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.64301596 |
39 | nitrogen cycle metabolic process (GO:0071941) | 4.61223175 |
40 | glycine metabolic process (GO:0006544) | 4.54313749 |
41 | plasma lipoprotein particle assembly (GO:0034377) | 4.49505025 |
42 | viral transcription (GO:0019083) | 4.47772889 |
43 | protein-lipid complex remodeling (GO:0034368) | 4.42045218 |
44 | macromolecular complex remodeling (GO:0034367) | 4.42045218 |
45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.42045218 |
46 | telomere maintenance via recombination (GO:0000722) | 4.41271826 |
47 | regulation of triglyceride catabolic process (GO:0010896) | 4.40624881 |
48 | translational termination (GO:0006415) | 4.33825047 |
49 | epoxygenase P450 pathway (GO:0019373) | 4.28243629 |
50 | phospholipid efflux (GO:0033700) | 4.24942192 |
51 | cholesterol efflux (GO:0033344) | 4.16874686 |
52 | serine family amino acid catabolic process (GO:0009071) | 4.09669943 |
53 | drug catabolic process (GO:0042737) | 4.09376286 |
54 | mitotic recombination (GO:0006312) | 4.08585814 |
55 | acute-phase response (GO:0006953) | 4.07545735 |
56 | protein-lipid complex assembly (GO:0065005) | 4.07514178 |
57 | DNA replication checkpoint (GO:0000076) | 4.06608577 |
58 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.06200121 |
59 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.06200121 |
60 | serine family amino acid biosynthetic process (GO:0009070) | 4.04558903 |
61 | DNA deamination (GO:0045006) | 4.00952516 |
62 | translational elongation (GO:0006414) | 3.97525767 |
63 | proline biosynthetic process (GO:0006561) | 3.96698823 |
64 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.94499497 |
65 | high-density lipoprotein particle remodeling (GO:0034375) | 3.93559783 |
66 | imidazole-containing compound metabolic process (GO:0052803) | 3.92464051 |
67 | cytolysis (GO:0019835) | 3.89841675 |
68 | plasma lipoprotein particle organization (GO:0071827) | 3.86919138 |
69 | low-density lipoprotein particle remodeling (GO:0034374) | 3.86012506 |
70 | regulation of cholesterol homeostasis (GO:2000188) | 3.82576793 |
71 | exogenous drug catabolic process (GO:0042738) | 3.82541550 |
72 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.82133609 |
73 | oxaloacetate metabolic process (GO:0006107) | 3.77418450 |
74 | plasma lipoprotein particle clearance (GO:0034381) | 3.74805790 |
75 | telomere maintenance via telomere lengthening (GO:0010833) | 3.72686773 |
76 | protein activation cascade (GO:0072376) | 3.72580985 |
77 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.72398448 |
78 | CENP-A containing nucleosome assembly (GO:0034080) | 3.70459289 |
79 | L-serine metabolic process (GO:0006563) | 3.69945993 |
80 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.69671256 |
81 | omega-hydroxylase P450 pathway (GO:0097267) | 3.69601829 |
82 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.69033038 |
83 | protein-lipid complex subunit organization (GO:0071825) | 3.67808124 |
84 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.67611706 |
85 | protein localization to kinetochore (GO:0034501) | 3.66823366 |
86 | IMP biosynthetic process (GO:0006188) | 3.66116288 |
87 | positive regulation of blood coagulation (GO:0030194) | 3.65149626 |
88 | positive regulation of hemostasis (GO:1900048) | 3.65149626 |
89 | serine family amino acid metabolic process (GO:0009069) | 3.63973445 |
90 | acylglycerol homeostasis (GO:0055090) | 3.63508573 |
91 | triglyceride homeostasis (GO:0070328) | 3.63508573 |
92 | regulation of apoptotic cell clearance (GO:2000425) | 3.62432873 |
93 | maturation of SSU-rRNA (GO:0030490) | 3.60403113 |
94 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.60237220 |
95 | ethanol oxidation (GO:0006069) | 3.60224692 |
96 | negative regulation of hemostasis (GO:1900047) | 3.59262416 |
97 | negative regulation of blood coagulation (GO:0030195) | 3.59262416 |
98 | regulation of humoral immune response (GO:0002920) | 3.58478191 |
99 | cotranslational protein targeting to membrane (GO:0006613) | 3.57446663 |
100 | protein targeting to ER (GO:0045047) | 3.57122482 |
101 | erythrocyte development (GO:0048821) | 3.53320087 |
102 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.52693022 |
103 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.50876058 |
104 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.50876058 |
105 | chromatin remodeling at centromere (GO:0031055) | 3.50823492 |
106 | ribosomal small subunit biogenesis (GO:0042274) | 3.50058985 |
107 | protein localization to chromosome, centromeric region (GO:0071459) | 3.49690314 |
108 | kinetochore organization (GO:0051383) | 3.47265313 |
109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.46425278 |
110 | translational initiation (GO:0006413) | 3.46054660 |
111 | pigment biosynthetic process (GO:0046148) | 3.45131806 |
112 | complement activation, classical pathway (GO:0006958) | 3.43679888 |
113 | reverse cholesterol transport (GO:0043691) | 3.41009955 |
114 | negative regulation of protein activation cascade (GO:2000258) | 3.39810575 |
115 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.39594044 |
116 | glutamate metabolic process (GO:0006536) | 3.39138245 |
117 | DNA replication-independent nucleosome organization (GO:0034724) | 3.38991181 |
118 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.38991181 |
119 | protein localization to endoplasmic reticulum (GO:0070972) | 3.36719060 |
120 | regulation of lipoprotein particle clearance (GO:0010984) | 3.35942127 |
121 | cellular protein complex disassembly (GO:0043624) | 3.34544867 |
122 | aromatic amino acid family catabolic process (GO:0009074) | 3.34437740 |
123 | tetrapyrrole metabolic process (GO:0033013) | 3.32943174 |
124 | complement activation (GO:0006956) | 3.32328776 |
125 | positive regulation of coagulation (GO:0050820) | 3.29275553 |
126 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.26639445 |
127 | viral life cycle (GO:0019058) | 3.25474618 |
128 | IMP metabolic process (GO:0046040) | 3.24706292 |
129 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.23491338 |
130 | formation of translation preinitiation complex (GO:0001731) | 3.21100682 |
131 | negative regulation of coagulation (GO:0050819) | 3.20413735 |
132 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.19267063 |
133 | meiotic chromosome segregation (GO:0045132) | 3.18144534 |
134 | bile acid biosynthetic process (GO:0006699) | 3.17946965 |
135 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.17885971 |
136 | drug metabolic process (GO:0017144) | 3.17127248 |
137 | cysteine metabolic process (GO:0006534) | 3.13578648 |
138 | tyrosine metabolic process (GO:0006570) | 3.12306257 |
139 | bile acid metabolic process (GO:0008206) | 3.12236668 |
140 | cellular glucuronidation (GO:0052695) | 3.12059493 |
141 | tetrahydrofolate metabolic process (GO:0046653) | 3.09851962 |
142 | protein complex disassembly (GO:0043241) | 3.08724231 |
143 | phenylpropanoid metabolic process (GO:0009698) | 3.07489543 |
144 | mitotic sister chromatid segregation (GO:0000070) | 3.06370740 |
145 | negative regulation of wound healing (GO:0061045) | 3.06314372 |
146 | mitotic nuclear envelope disassembly (GO:0007077) | 3.04244953 |
147 | kinetochore assembly (GO:0051382) | 3.03446689 |
148 | glucuronate metabolic process (GO:0019585) | 3.02418701 |
149 | uronic acid metabolic process (GO:0006063) | 3.02418701 |
150 | regulation of response to tumor cell (GO:0002834) | 2.99827905 |
151 | positive regulation of response to tumor cell (GO:0002836) | 2.99827905 |
152 | positive regulation of immune response to tumor cell (GO:0002839) | 2.99827905 |
153 | regulation of immune response to tumor cell (GO:0002837) | 2.99827905 |
154 | acute inflammatory response (GO:0002526) | 2.98189095 |
155 | negative regulation of lipase activity (GO:0060192) | 2.97666535 |
156 | negative regulation of RNA splicing (GO:0033119) | 2.96729943 |
157 | nucleobase biosynthetic process (GO:0046112) | 2.96592661 |
158 | ethanol metabolic process (GO:0006067) | 2.95687253 |
159 | hemoglobin metabolic process (GO:0020027) | 2.94599963 |
160 | regulation of histone H3-K9 methylation (GO:0051570) | 2.93677615 |
161 | pigment metabolic process (GO:0042440) | 2.92542595 |
162 | macromolecular complex disassembly (GO:0032984) | 2.88121878 |
163 | translesion synthesis (GO:0019985) | 2.86787923 |
164 | purine-containing compound salvage (GO:0043101) | 2.86479387 |
165 | telomere maintenance (GO:0000723) | 2.85674299 |
166 | chromatin assembly or disassembly (GO:0006333) | 2.85605333 |
167 | sister chromatid segregation (GO:0000819) | 2.85579585 |
168 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.85525894 |
169 | definitive hemopoiesis (GO:0060216) | 2.85462554 |
170 | mitotic chromosome condensation (GO:0007076) | 2.85345655 |
171 | telomere organization (GO:0032200) | 2.85307752 |
172 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.83129856 |
173 | histone exchange (GO:0043486) | 2.81533776 |
174 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.80231726 |
175 | erythrocyte differentiation (GO:0030218) | 2.79963075 |
176 | ribosomal large subunit biogenesis (GO:0042273) | 2.79685871 |
177 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.78732618 |
178 | DNA duplex unwinding (GO:0032508) | 2.76934900 |
179 | nuclear envelope disassembly (GO:0051081) | 2.76278058 |
180 | membrane disassembly (GO:0030397) | 2.76278058 |
181 | DNA geometric change (GO:0032392) | 2.74260429 |
182 | DNA topological change (GO:0006265) | 2.70558048 |
183 | RNA catabolic process (GO:0006401) | 2.69164276 |
184 | mRNA catabolic process (GO:0006402) | 2.68142417 |
185 | response to lead ion (GO:0010288) | 2.65981482 |
186 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.65939968 |
187 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.65921189 |
188 | pseudouridine synthesis (GO:0001522) | 2.64701656 |
189 | translation (GO:0006412) | 2.62690276 |
190 | protein autoprocessing (GO:0016540) | 2.61916858 |
191 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.59550800 |
192 | one-carbon compound transport (GO:0019755) | 2.56492328 |
193 | purine nucleobase biosynthetic process (GO:0009113) | 2.56137298 |
194 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.55940284 |
195 | mitotic metaphase plate congression (GO:0007080) | 2.54908537 |
196 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.53463813 |
197 | cell cycle G1/S phase transition (GO:0044843) | 2.51147652 |
198 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.51147652 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.22170111 |
2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.80386303 |
3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.69753210 |
4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.53679204 |
5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.50090042 |
6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.44542095 |
7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.88298857 |
8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.50076184 |
9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.44484474 |
10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.33984048 |
11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.31735150 |
12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.30952984 |
13 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.27724657 |
14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.25891214 |
15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.19642394 |
16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.16433356 |
17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.14290035 |
18 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06688250 |
19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.06613374 |
20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.06107563 |
21 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05534522 |
22 | * MYC_22102868_ChIP-Seq_BL_Human | 2.00881786 |
23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.00022458 |
24 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.99690480 |
25 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.99076360 |
26 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.95791954 |
27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.95347250 |
28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.94218510 |
29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.92795808 |
30 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.92156064 |
31 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.86888930 |
32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.86795951 |
33 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.82645567 |
34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78633103 |
35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.77890764 |
36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.73966664 |
37 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68531049 |
38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.67628499 |
39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65931041 |
40 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.61617929 |
41 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.61116253 |
42 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.60237631 |
43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.59773153 |
44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.58992733 |
45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58009448 |
46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.57578405 |
47 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.56555951 |
48 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.56521466 |
49 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.56042221 |
50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.54901733 |
51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53408721 |
52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.52518506 |
53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.52094895 |
54 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.49913676 |
55 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.49668191 |
56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.45669855 |
57 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.44108552 |
58 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43305768 |
59 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.42167834 |
60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.40201568 |
61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39447034 |
62 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37620361 |
63 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35029614 |
64 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35026561 |
65 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.33983757 |
66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33154086 |
67 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32361677 |
68 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31042521 |
69 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.30022603 |
70 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.29864310 |
71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.28866023 |
72 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28192360 |
73 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27464800 |
74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27144841 |
75 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.25420824 |
76 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.25374317 |
77 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24384289 |
78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22370625 |
79 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.20743794 |
80 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.20713611 |
81 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.20582144 |
82 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.19487037 |
83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19163966 |
84 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17790790 |
85 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17284945 |
86 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.14537359 |
87 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14470628 |
88 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.14164833 |
89 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.11353305 |
90 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11231092 |
91 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09856446 |
92 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.08996136 |
93 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08687297 |
94 | P68_20966046_ChIP-Seq_HELA_Human | 1.08151430 |
95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07597579 |
96 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07043615 |
97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06482719 |
98 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06009639 |
99 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05257861 |
100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04827909 |
101 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04567248 |
102 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03865406 |
103 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03745315 |
104 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03586476 |
105 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03467372 |
106 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.03209391 |
107 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03044770 |
108 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.02357076 |
109 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02293143 |
110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.01258779 |
111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00937676 |
112 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.00922893 |
113 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00371598 |
114 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99639671 |
115 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.99566327 |
116 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98319973 |
117 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98087663 |
118 | MAF_26560356_Chip-Seq_TH1_Human | 0.96653894 |
119 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.96436288 |
120 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95616926 |
121 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94940482 |
122 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93565675 |
123 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.93275980 |
124 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.93153941 |
125 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92992336 |
126 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.92508807 |
127 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92213176 |
128 | MYB_26560356_Chip-Seq_TH1_Human | 0.91078847 |
129 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90758460 |
130 | MAF_26560356_Chip-Seq_TH2_Human | 0.90381155 |
131 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.90166636 |
132 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.89211155 |
133 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.87987537 |
134 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.85397074 |
135 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.85256248 |
136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83034295 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003656_abnormal_erythrocyte_physiolo | 6.45077257 |
2 | MP0004147_increased_porphyrin_level | 6.16432850 |
3 | MP0010094_abnormal_chromosome_stability | 3.72858938 |
4 | MP0001666_abnormal_nutrient_absorption | 3.47988637 |
5 | MP0003693_abnormal_embryo_hatching | 3.44008348 |
6 | MP0003111_abnormal_nucleus_morphology | 3.40805019 |
7 | MP0002396_abnormal_hematopoietic_system | 3.18791350 |
8 | MP0008057_abnormal_DNA_replication | 3.04877092 |
9 | MP0003195_calcinosis | 2.95516537 |
10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.95488897 |
11 | MP0003077_abnormal_cell_cycle | 2.88544135 |
12 | MP0003868_abnormal_feces_composition | 2.85825774 |
13 | MP0005397_hematopoietic_system_phenotyp | 2.81043861 |
14 | MP0001545_abnormal_hematopoietic_system | 2.81043861 |
15 | MP0002138_abnormal_hepatobiliary_system | 2.77386106 |
16 | MP0005670_abnormal_white_adipose | 2.76197820 |
17 | MP0005451_abnormal_body_composition | 2.70731151 |
18 | MP0004957_abnormal_blastocyst_morpholog | 2.70663191 |
19 | MP0006054_spinal_hemorrhage | 2.68889858 |
20 | MP0009840_abnormal_foam_cell | 2.36210419 |
21 | MP0008058_abnormal_DNA_repair | 2.34949323 |
22 | MP0003806_abnormal_nucleotide_metabolis | 2.26546835 |
23 | MP0003252_abnormal_bile_duct | 2.16566123 |
24 | MP0004808_abnormal_hematopoietic_stem | 1.94621558 |
25 | MP0005332_abnormal_amino_acid | 1.91533675 |
26 | MP0000490_abnormal_crypts_of | 1.88112042 |
27 | MP0008007_abnormal_cellular_replicative | 1.83813552 |
28 | MP0006036_abnormal_mitochondrial_physio | 1.74851238 |
29 | MP0005058_abnormal_lysosome_morphology | 1.73616164 |
30 | MP0005083_abnormal_biliary_tract | 1.72776591 |
31 | MP0002139_abnormal_hepatobiliary_system | 1.68873094 |
32 | MP0002398_abnormal_bone_marrow | 1.68007130 |
33 | MP0003172_abnormal_lysosome_physiology | 1.63691486 |
34 | MP0001661_extended_life_span | 1.61732405 |
35 | MP0003186_abnormal_redox_activity | 1.59647961 |
36 | MP0000685_abnormal_immune_system | 1.53348225 |
37 | MP0002722_abnormal_immune_system | 1.52832846 |
38 | MP0000689_abnormal_spleen_morphology | 1.52782815 |
39 | MP0002118_abnormal_lipid_homeostasis | 1.46615671 |
40 | MP0009333_abnormal_splenocyte_physiolog | 1.43648109 |
41 | MP0008932_abnormal_embryonic_tissue | 1.43511463 |
42 | MP0000350_abnormal_cell_proliferation | 1.42688646 |
43 | MP0002132_abnormal_respiratory_system | 1.40920144 |
44 | MP0005076_abnormal_cell_differentiation | 1.40648050 |
45 | MP0010307_abnormal_tumor_latency | 1.38008441 |
46 | MP0002019_abnormal_tumor_incidence | 1.37068134 |
47 | MP0003763_abnormal_thymus_physiology | 1.36760305 |
48 | MP0003183_abnormal_peptide_metabolism | 1.31408802 |
49 | MP0002429_abnormal_blood_cell | 1.30261551 |
50 | MP0001730_embryonic_growth_arrest | 1.29704466 |
51 | MP0000703_abnormal_thymus_morphology | 1.29525120 |
52 | MP0005464_abnormal_platelet_physiology | 1.28139030 |
53 | MP0000313_abnormal_cell_death | 1.23182019 |
54 | MP0005636_abnormal_mineral_homeostasis | 1.21259546 |
55 | MP0005220_abnormal_exocrine_pancreas | 1.20879968 |
56 | MP0005085_abnormal_gallbladder_physiolo | 1.15787353 |
57 | MP0010352_gastrointestinal_tract_polyps | 1.13742089 |
58 | MP0005365_abnormal_bile_salt | 1.11332576 |
59 | MP0003436_decreased_susceptibility_to | 1.10281846 |
60 | MP0009278_abnormal_bone_marrow | 1.08423963 |
61 | MP0002080_prenatal_lethality | 1.07301097 |
62 | MP0002166_altered_tumor_susceptibility | 1.06055347 |
63 | MP0005666_abnormal_adipose_tissue | 1.04013041 |
64 | MP0005671_abnormal_response_to | 1.03966990 |
65 | MP0003567_abnormal_fetal_cardiomyocyte | 1.03242108 |
66 | MP0005408_hypopigmentation | 0.99978283 |
67 | MP0001853_heart_inflammation | 0.99786373 |
68 | MP0001697_abnormal_embryo_size | 0.98795552 |
69 | MP0005360_urolithiasis | 0.98621085 |
70 | MP0000716_abnormal_immune_system | 0.97227017 |
71 | MP0002876_abnormal_thyroid_physiology | 0.96832289 |
72 | MP0002086_abnormal_extraembryonic_tissu | 0.96404726 |
73 | MP0000598_abnormal_liver_morphology | 0.96272770 |
74 | MP0001764_abnormal_homeostasis | 0.94231869 |
75 | MP0003786_premature_aging | 0.93270614 |
76 | MP0004197_abnormal_fetal_growth/weight/ | 0.92919619 |
77 | MP0003984_embryonic_growth_retardation | 0.92863516 |
78 | MP0003123_paternal_imprinting | 0.92808739 |
79 | MP0000609_abnormal_liver_physiology | 0.92699108 |
80 | MP0009643_abnormal_urine_homeostasis | 0.92565761 |
81 | MP0005075_abnormal_melanosome_morpholog | 0.91977362 |
82 | MP0001672_abnormal_embryogenesis/_devel | 0.91488630 |
83 | MP0005380_embryogenesis_phenotype | 0.91488630 |
84 | MP0002088_abnormal_embryonic_growth/wei | 0.89812768 |
85 | MP0009642_abnormal_blood_homeostasis | 0.86772967 |
86 | MP0004233_abnormal_muscle_weight | 0.86573061 |
87 | MP0002095_abnormal_skin_pigmentation | 0.86167468 |
88 | MP0001835_abnormal_antigen_presentation | 0.85431878 |
89 | MP0002971_abnormal_brown_adipose | 0.84556078 |
90 | MP0008775_abnormal_heart_ventricle | 0.84276939 |
91 | MP0001800_abnormal_humoral_immune | 0.83095549 |
92 | MP0009931_abnormal_skin_appearance | 0.80751514 |
93 | MP0003959_abnormal_lean_body | 0.77417886 |
94 | MP0002089_abnormal_postnatal_growth/wei | 0.77264559 |
95 | MP0000749_muscle_degeneration | 0.76364785 |
96 | MP0000604_amyloidosis | 0.76348199 |
97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75539176 |
98 | MP0008260_abnormal_autophagy | 0.75086904 |
99 | MP0000465_gastrointestinal_hemorrhage | 0.74721335 |
100 | MP0002006_tumorigenesis | 0.73430908 |
101 | MP0005376_homeostasis/metabolism_phenot | 0.72155888 |
102 | MP0005025_abnormal_response_to | 0.71424195 |
103 | MP0010368_abnormal_lymphatic_system | 0.70659105 |
104 | MP0005319_abnormal_enzyme/_coenzyme | 0.70611958 |
105 | MP0002420_abnormal_adaptive_immunity | 0.70492266 |
106 | MP0004185_abnormal_adipocyte_glucose | 0.70077543 |
107 | MP0009697_abnormal_copulation | 0.69167279 |
108 | MP0002970_abnormal_white_adipose | 0.68837445 |
109 | MP0001819_abnormal_immune_cell | 0.68663262 |
110 | MP0001243_abnormal_dermal_layer | 0.68518359 |
111 | MP0009785_altered_susceptibility_to | 0.67955872 |
112 | MP0005174_abnormal_tail_pigmentation | 0.67796963 |
113 | MP0010329_abnormal_lipoprotein_level | 0.67340459 |
114 | MP0006035_abnormal_mitochondrial_morpho | 0.66882735 |
115 | MP0001915_intracranial_hemorrhage | 0.66046403 |
116 | MP0002405_respiratory_system_inflammati | 0.65787874 |
117 | MP0005375_adipose_tissue_phenotype | 0.64081374 |
118 | MP0009763_increased_sensitivity_to | 0.63727993 |
119 | MP0002452_abnormal_antigen_presenting | 0.63339559 |
120 | MP0000358_abnormal_cell_content/ | 0.63129565 |
121 | MP0002078_abnormal_glucose_homeostasis | 0.62979288 |
122 | MP0000858_altered_metastatic_potential | 0.62872636 |
123 | MP0005501_abnormal_skin_physiology | 0.62404245 |
124 | MP0009115_abnormal_fat_cell | 0.61846404 |
125 | MP0008770_decreased_survivor_rate | 0.61332968 |
126 | MP0005266_abnormal_metabolism | 0.61073147 |
127 | MP0003191_abnormal_cellular_cholesterol | 0.60677206 |
128 | MP0003943_abnormal_hepatobiliary_system | 0.60274322 |
129 | MP0008469_abnormal_protein_level | 0.60274015 |
130 | MP0009672_abnormal_birth_weight | 0.59025350 |
131 | MP0009379_abnormal_foot_pigmentation | 0.57978695 |
132 | MP0002419_abnormal_innate_immunity | 0.57894783 |
133 | MP0002723_abnormal_immune_serum | 0.57285233 |
134 | MP0002085_abnormal_embryonic_tissue | 0.57182219 |
135 | MP0000477_abnormal_intestine_morphology | 0.56918042 |
136 | MP0003718_maternal_effect | 0.56883840 |
137 | MP0010155_abnormal_intestine_physiology | 0.56302754 |
138 | MP0001845_abnormal_inflammatory_respons | 0.54946458 |
139 | MP0003303_peritoneal_inflammation | 0.54767175 |
140 | MP0005334_abnormal_fat_pad | 0.54447966 |
141 | MP0005395_other_phenotype | 0.53617386 |
142 | MP0000747_muscle_weakness | 0.53046676 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 8.67257309 |
2 | Poikilocytosis (HP:0004447) | 7.67689386 |
3 | Prolonged partial thromboplastin time (HP:0003645) | 6.71911744 |
4 | Abnormal number of erythroid precursors (HP:0012131) | 6.26173214 |
5 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.07320343 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.04808252 |
7 | Complement deficiency (HP:0004431) | 6.00941225 |
8 | Hypobetalipoproteinemia (HP:0003563) | 5.78783310 |
9 | Acanthocytosis (HP:0001927) | 5.49761735 |
10 | Joint hemorrhage (HP:0005261) | 5.37677696 |
11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.20097714 |
12 | Reticulocytosis (HP:0001923) | 5.10406142 |
13 | Abnormality of complement system (HP:0005339) | 4.94428708 |
14 | Hypochromic microcytic anemia (HP:0004840) | 4.61588367 |
15 | Abnormality of reticulocytes (HP:0004312) | 4.57605269 |
16 | Birth length less than 3rd percentile (HP:0003561) | 4.47737105 |
17 | Systemic lupus erythematosus (HP:0002725) | 4.35636960 |
18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.21788399 |
19 | Hyperbilirubinemia (HP:0002904) | 4.04612539 |
20 | Xanthomatosis (HP:0000991) | 3.91301446 |
21 | Glomerulonephritis (HP:0000099) | 3.80626962 |
22 | Reticulocytopenia (HP:0001896) | 3.63737050 |
23 | Cholelithiasis (HP:0001081) | 3.53942789 |
24 | Petechiae (HP:0000967) | 3.46549640 |
25 | Paralysis (HP:0003470) | 3.42092643 |
26 | Hypolipoproteinemia (HP:0010981) | 3.41203115 |
27 | Hemorrhage of the eye (HP:0011885) | 3.39414088 |
28 | Aplastic anemia (HP:0001915) | 3.37471112 |
29 | Spontaneous abortion (HP:0005268) | 3.32986133 |
30 | Diaphragmatic weakness (HP:0009113) | 3.28429955 |
31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.26137914 |
32 | Microcytic anemia (HP:0001935) | 3.24831785 |
33 | Pallor (HP:0000980) | 3.23712476 |
34 | Prolonged bleeding time (HP:0003010) | 3.21203489 |
35 | Intrahepatic cholestasis (HP:0001406) | 3.15806699 |
36 | Macrocytic anemia (HP:0001972) | 3.11925325 |
37 | Abnormal gallbladder morphology (HP:0012437) | 3.09806945 |
38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.07971464 |
39 | Hypochromic anemia (HP:0001931) | 3.05379967 |
40 | Increased serum ferritin (HP:0003281) | 2.97638728 |
41 | Menorrhagia (HP:0000132) | 2.94863807 |
42 | Hyperlipoproteinemia (HP:0010980) | 2.82619076 |
43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.82287191 |
44 | Thrombocytosis (HP:0001894) | 2.68101274 |
45 | Abnormality of iron homeostasis (HP:0011031) | 2.67903742 |
46 | Hypercholesterolemia (HP:0003124) | 2.63999785 |
47 | Cutaneous photosensitivity (HP:0000992) | 2.63976899 |
48 | Hyperammonemia (HP:0001987) | 2.62840557 |
49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.59318974 |
50 | Fat malabsorption (HP:0002630) | 2.58853724 |
51 | Nausea (HP:0002018) | 2.56033241 |
52 | Epistaxis (HP:0000421) | 2.52706663 |
53 | Oral leukoplakia (HP:0002745) | 2.51164745 |
54 | Hepatocellular carcinoma (HP:0001402) | 2.46161818 |
55 | Myocardial infarction (HP:0001658) | 2.45401811 |
56 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.41868389 |
57 | Hypoalphalipoproteinemia (HP:0003233) | 2.39166241 |
58 | Increased serum pyruvate (HP:0003542) | 2.37592015 |
59 | Insomnia (HP:0100785) | 2.37522726 |
60 | Polycythemia (HP:0001901) | 2.33059572 |
61 | Gout (HP:0001997) | 2.32224659 |
62 | Hyperglycinemia (HP:0002154) | 2.32199871 |
63 | Abnormality of glycolysis (HP:0004366) | 2.31191384 |
64 | IgM deficiency (HP:0002850) | 2.29433889 |
65 | Myelodysplasia (HP:0002863) | 2.26308910 |
66 | Osteomalacia (HP:0002749) | 2.25778474 |
67 | Abnormality of methionine metabolism (HP:0010901) | 2.23856047 |
68 | Nephritis (HP:0000123) | 2.23130194 |
69 | Abnormality of the gallbladder (HP:0005264) | 2.22803516 |
70 | Selective tooth agenesis (HP:0001592) | 2.17904047 |
71 | Abnormality of the Achilles tendon (HP:0005109) | 2.15054689 |
72 | Basal cell carcinoma (HP:0002671) | 2.14881280 |
73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.13854062 |
74 | Abnormality of glycine metabolism (HP:0010895) | 2.13116320 |
75 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.13116320 |
76 | Breast hypoplasia (HP:0003187) | 2.09214030 |
77 | Seborrheic dermatitis (HP:0001051) | 2.08895032 |
78 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08693875 |
79 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08693875 |
80 | Cholecystitis (HP:0001082) | 2.08362224 |
81 | Abnormal gallbladder physiology (HP:0012438) | 2.08362224 |
82 | Steatorrhea (HP:0002570) | 2.06456199 |
83 | Acute hepatic failure (HP:0006554) | 2.03899656 |
84 | Short middle phalanx of the 5th finger (HP:0004220) | 2.03638841 |
85 | Nonimmune hydrops fetalis (HP:0001790) | 2.02882949 |
86 | Patellar aplasia (HP:0006443) | 2.00644308 |
87 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 11.0235302 |
88 | Chromsome breakage (HP:0040012) | 1.98537808 |
89 | Hyperglycinuria (HP:0003108) | 1.97898675 |
90 | Purpura (HP:0000979) | 1.97894330 |
91 | Reduced antithrombin III activity (HP:0001976) | 1.95777137 |
92 | Ileus (HP:0002595) | 1.94193023 |
93 | Multiple enchondromatosis (HP:0005701) | 1.93020436 |
94 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.91738842 |
95 | Generalized aminoaciduria (HP:0002909) | 1.91363168 |
96 | Pulmonary embolism (HP:0002204) | 1.91168724 |
97 | Rickets (HP:0002748) | 1.90060046 |
98 | Lymphoma (HP:0002665) | 1.89653278 |
99 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.89492046 |
100 | Abnormality of chromosome stability (HP:0003220) | 1.88430096 |
101 | Impaired platelet aggregation (HP:0003540) | 1.88269174 |
102 | Abnormal platelet function (HP:0011869) | 1.88269174 |
103 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.87438277 |
104 | Abnormal platelet volume (HP:0011876) | 1.86361876 |
105 | 11 pairs of ribs (HP:0000878) | 1.84798954 |
106 | Microretrognathia (HP:0000308) | 1.83803657 |
107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83433027 |
108 | Vascular calcification (HP:0004934) | 1.82900578 |
109 | Recurrent viral infections (HP:0004429) | 1.82598465 |
110 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.80825868 |
111 | Broad palm (HP:0001169) | 1.80715660 |
112 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.79814691 |
113 | Medulloblastoma (HP:0002885) | 1.79600666 |
114 | Abnormality of B cell number (HP:0010975) | 1.78943376 |
115 | B lymphocytopenia (HP:0010976) | 1.78943376 |
116 | Pancytopenia (HP:0001876) | 1.76811431 |
117 | Spastic paraparesis (HP:0002313) | 1.76114176 |
118 | Colitis (HP:0002583) | 1.75972859 |
119 | Elevated alkaline phosphatase (HP:0003155) | 1.75049763 |
120 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.74693943 |
121 | Abnormality of serum amino acid levels (HP:0003112) | 1.74179700 |
122 | Hypertriglyceridemia (HP:0002155) | 1.72980101 |
123 | Colon cancer (HP:0003003) | 1.70149767 |
124 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.69329078 |
125 | Increased mean platelet volume (HP:0011877) | 1.68712961 |
126 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.68356666 |
127 | High pitched voice (HP:0001620) | 1.68100792 |
128 | Amaurosis fugax (HP:0100576) | 1.67826758 |
129 | Hypoglycemic coma (HP:0001325) | 1.67604942 |
130 | Meckel diverticulum (HP:0002245) | 1.66422365 |
131 | Lower limb hyperreflexia (HP:0002395) | 1.66385341 |
132 | Autoimmune thrombocytopenia (HP:0001973) | 1.65064916 |
133 | Abnormality of the ileum (HP:0001549) | 1.64768146 |
134 | Rhabdomyolysis (HP:0003201) | 1.63819538 |
135 | Increased serum lactate (HP:0002151) | 1.63270306 |
136 | Self-mutilation (HP:0000742) | 1.63176440 |
137 | Hypoplasia of the thymus (HP:0000778) | 1.63142317 |
138 | Cerebral palsy (HP:0100021) | 1.61508238 |
139 | Small intestinal stenosis (HP:0012848) | 1.61184837 |
140 | Duodenal stenosis (HP:0100867) | 1.61184837 |
141 | Vertebral compression fractures (HP:0002953) | 1.60667546 |
142 | Type I transferrin isoform profile (HP:0003642) | 1.57917175 |
143 | Abnormal hemoglobin (HP:0011902) | 1.57772335 |
144 | Abnormality of the thoracic spine (HP:0100711) | 1.57183355 |
145 | Abnormality of T cell physiology (HP:0011840) | 1.56506578 |
146 | Abnormality of the fingertips (HP:0001211) | 1.55711303 |
147 | Metabolic acidosis (HP:0001942) | 1.55709075 |
148 | Abnormality of T cells (HP:0002843) | 1.55496996 |
149 | Abnormality of the preputium (HP:0100587) | 1.55398478 |
150 | Elevated hepatic transaminases (HP:0002910) | 1.55211081 |
151 | Rhabdomyosarcoma (HP:0002859) | 1.54912930 |
152 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.54784274 |
153 | Abnormality of carpal bone ossification (HP:0006257) | 1.54662560 |
154 | Pustule (HP:0200039) | 1.54623225 |
155 | Panhypogammaglobulinemia (HP:0003139) | 1.54615776 |
156 | Slender long bone (HP:0003100) | 1.54225221 |
157 | Cellular immunodeficiency (HP:0005374) | 1.53568951 |
158 | Combined immunodeficiency (HP:0005387) | 1.51649164 |
159 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.51542044 |
160 | Gingival bleeding (HP:0000225) | 1.51120945 |
161 | Bone marrow hypocellularity (HP:0005528) | 1.50611108 |
162 | Hypoplasia of the pons (HP:0012110) | 1.50494420 |
163 | Thrombophlebitis (HP:0004418) | 1.50210878 |
164 | Abnormal spermatogenesis (HP:0008669) | 1.49216631 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EIF2AK1 | 4.34670958 |
2 | CDC7 | 4.08297256 |
3 | FGFR4 | 3.12610960 |
4 | NME2 | 3.10463045 |
5 | PRPF4B | 3.10309700 |
6 | WEE1 | 2.83587108 |
7 | SMG1 | 2.81316993 |
8 | NEK2 | 2.48604084 |
9 | BUB1 | 2.45480785 |
10 | EEF2K | 2.36700700 |
11 | ICK | 2.20948096 |
12 | IRAK3 | 2.09118054 |
13 | MAP3K10 | 2.03698109 |
14 | VRK1 | 2.03434413 |
15 | MAP2K3 | 1.91745986 |
16 | TLK1 | 1.88042600 |
17 | DYRK3 | 1.87859927 |
18 | FLT3 | 1.86516311 |
19 | NEK1 | 1.84498275 |
20 | STK4 | 1.83834281 |
21 | BRSK2 | 1.80224657 |
22 | ACVR1B | 1.80219429 |
23 | MAP4K1 | 1.74488628 |
24 | STK16 | 1.73425640 |
25 | MAP2K6 | 1.63249003 |
26 | BRSK1 | 1.62123576 |
27 | PKN2 | 1.56340926 |
28 | BCKDK | 1.55682387 |
29 | RPS6KB2 | 1.52521179 |
30 | STK10 | 1.52356754 |
31 | KDR | 1.51872308 |
32 | SRPK1 | 1.50847051 |
33 | ATR | 1.50655650 |
34 | CDK4 | 1.46031089 |
35 | TGFBR1 | 1.45169251 |
36 | AURKB | 1.44556113 |
37 | SCYL2 | 1.44507479 |
38 | EIF2AK3 | 1.40002214 |
39 | PIM2 | 1.35267668 |
40 | TTK | 1.33345909 |
41 | PIM1 | 1.30214540 |
42 | PLK1 | 1.28298429 |
43 | CCNB1 | 1.27152297 |
44 | CDK7 | 1.26284430 |
45 | PLK4 | 1.19658947 |
46 | CAMK1D | 1.19046024 |
47 | MAPK11 | 1.18835176 |
48 | MAP3K8 | 1.17836368 |
49 | RPS6KA4 | 1.16156931 |
50 | MAP3K11 | 1.13010309 |
51 | ZAK | 1.12930227 |
52 | MKNK1 | 1.10968799 |
53 | LRRK2 | 1.05100930 |
54 | FGFR3 | 1.01114289 |
55 | CHEK2 | 0.99262367 |
56 | TRIB3 | 0.97841810 |
57 | TGFBR2 | 0.96823306 |
58 | AURKA | 0.96696584 |
59 | CDK6 | 0.95224137 |
60 | BTK | 0.92473506 |
61 | GRK6 | 0.91695372 |
62 | WNK4 | 0.91193514 |
63 | TYK2 | 0.90582521 |
64 | RIPK4 | 0.87166663 |
65 | CLK1 | 0.84536593 |
66 | MAPKAPK3 | 0.83249224 |
67 | TAOK1 | 0.82892704 |
68 | CHEK1 | 0.82543024 |
69 | JAK3 | 0.81814304 |
70 | PASK | 0.81801826 |
71 | SYK | 0.81279431 |
72 | CDK12 | 0.80829334 |
73 | TEC | 0.80009640 |
74 | PRKAA2 | 0.79762963 |
75 | ERN1 | 0.78034458 |
76 | MTOR | 0.77527288 |
77 | PDPK1 | 0.77217620 |
78 | ITK | 0.77114581 |
79 | MAP3K1 | 0.76044087 |
80 | RPS6KA5 | 0.71004950 |
81 | ATM | 0.70903585 |
82 | MAP3K13 | 0.70403624 |
83 | WNK1 | 0.70368438 |
84 | KIT | 0.69705495 |
85 | TSSK6 | 0.66376318 |
86 | CAMK1G | 0.65993371 |
87 | CDK8 | 0.64520736 |
88 | ZAP70 | 0.62450995 |
89 | TESK2 | 0.62421239 |
90 | EIF2AK2 | 0.62329178 |
91 | VRK2 | 0.62203282 |
92 | PDK1 | 0.61851477 |
93 | LYN | 0.61263511 |
94 | RIPK1 | 0.61142315 |
95 | TAOK2 | 0.60871858 |
96 | TAOK3 | 0.60477478 |
97 | CSF1R | 0.60299351 |
98 | DYRK1B | 0.59607623 |
99 | BMX | 0.57628871 |
100 | MAP3K5 | 0.57128190 |
101 | CSNK2A1 | 0.55917517 |
102 | CDK2 | 0.54297649 |
103 | JAK2 | 0.53846168 |
104 | SIK1 | 0.53808398 |
105 | CSNK2A2 | 0.52094435 |
106 | MKNK2 | 0.51080985 |
107 | IRAK4 | 0.49299393 |
108 | TBK1 | 0.48219016 |
109 | BRD4 | 0.48133545 |
110 | MAPKAPK5 | 0.47718805 |
111 | TRPM7 | 0.47270139 |
112 | PBK | 0.47267713 |
113 | MAP3K6 | 0.44651249 |
114 | MAPK12 | 0.44312015 |
115 | PLK3 | 0.44055151 |
116 | RPS6KB1 | 0.43802361 |
117 | TNK2 | 0.41822960 |
118 | TIE1 | 0.41648280 |
119 | RPS6KC1 | 0.41083441 |
120 | RPS6KL1 | 0.41083441 |
121 | MAP2K2 | 0.40959338 |
122 | PRKAA1 | 0.40800160 |
123 | CDK19 | 0.40780640 |
124 | RAF1 | 0.40648765 |
125 | ILK | 0.40480357 |
126 | PAK4 | 0.40006042 |
127 | FES | 0.39000201 |
128 | KSR2 | 0.38784788 |
129 | CDK1 | 0.38015808 |
130 | AKT2 | 0.37991079 |
131 | MAP3K3 | 0.36375074 |
132 | PRKACG | 0.36016112 |
133 | IKBKB | 0.34633293 |
134 | MAPKAPK2 | 0.33784637 |
135 | RPS6KA6 | 0.31057033 |
136 | ABL2 | 0.30523472 |
137 | PIK3CG | 0.29702525 |
138 | IKBKE | 0.29307330 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 5.55512863 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.15366508 |
3 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.97628230 |
4 | Mismatch repair_Homo sapiens_hsa03430 | 3.91976828 |
5 | Ribosome_Homo sapiens_hsa03010 | 3.60101824 |
6 | Base excision repair_Homo sapiens_hsa03410 | 2.94431707 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66560346 |
8 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.62877400 |
9 | Homologous recombination_Homo sapiens_hsa03440 | 2.58376095 |
10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.54251297 |
11 | Cell cycle_Homo sapiens_hsa04110 | 2.49054958 |
12 | Spliceosome_Homo sapiens_hsa03040 | 2.41941377 |
13 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.32112171 |
14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.23757065 |
15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.19283299 |
16 | Retinol metabolism_Homo sapiens_hsa00830 | 2.09130659 |
17 | Proteasome_Homo sapiens_hsa03050 | 2.02955751 |
18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00258389 |
19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.93515116 |
20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.92859405 |
21 | RNA transport_Homo sapiens_hsa03013 | 1.86974228 |
22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.74397010 |
23 | RNA polymerase_Homo sapiens_hsa03020 | 1.72400420 |
24 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.71494474 |
25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70326320 |
26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69397524 |
27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.68545971 |
28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.66979815 |
29 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.66056722 |
30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.61322145 |
31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53079448 |
32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.51802433 |
33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50203093 |
34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.40881478 |
35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.39284160 |
36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.38866432 |
37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38436723 |
38 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.31313900 |
39 | RNA degradation_Homo sapiens_hsa03018 | 1.30127081 |
40 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.29325251 |
41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28984185 |
42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28150482 |
43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21685648 |
44 | Bile secretion_Homo sapiens_hsa04976 | 1.20751742 |
45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20529973 |
46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19406156 |
47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16436661 |
48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.14047905 |
49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.07303476 |
50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06867837 |
51 | Purine metabolism_Homo sapiens_hsa00230 | 1.04490026 |
52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.03065555 |
53 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02406856 |
54 | Prion diseases_Homo sapiens_hsa05020 | 1.00957577 |
55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99492843 |
56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97743326 |
57 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96272102 |
58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.95967484 |
59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91396570 |
60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90819611 |
61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.90360869 |
62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89239402 |
63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88327849 |
64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87974606 |
65 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.86786227 |
66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86190475 |
67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85092299 |
68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84846671 |
69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83680092 |
70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81065026 |
71 | Alcoholism_Homo sapiens_hsa05034 | 0.79900395 |
72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79401122 |
73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74437753 |
74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73139953 |
75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71897389 |
76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71442670 |
77 | ABC transporters_Homo sapiens_hsa02010 | 0.68455691 |
78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.67037851 |
79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66582005 |
80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64912255 |
81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62365439 |
82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62228750 |
83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60665975 |
84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60088991 |
85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59455326 |
86 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.57894251 |
87 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56654400 |
88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56600545 |
89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55549994 |
90 | Measles_Homo sapiens_hsa05162 | 0.53500086 |
91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52783774 |
92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52354961 |
93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52234007 |
94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52192694 |
95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51995183 |
96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51959822 |
97 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.51225265 |
98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50799069 |
99 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50795392 |
100 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50181003 |
101 | Protein export_Homo sapiens_hsa03060 | 0.49805424 |
102 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.49021265 |
103 | Insulin resistance_Homo sapiens_hsa04931 | 0.47585971 |
104 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47184745 |
105 | Bladder cancer_Homo sapiens_hsa05219 | 0.43763624 |
106 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43126248 |
107 | Peroxisome_Homo sapiens_hsa04146 | 0.43002493 |
108 | Apoptosis_Homo sapiens_hsa04210 | 0.42992726 |
109 | Lysine degradation_Homo sapiens_hsa00310 | 0.42963395 |
110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42771369 |
111 | Hepatitis B_Homo sapiens_hsa05161 | 0.42090953 |
112 | Legionellosis_Homo sapiens_hsa05134 | 0.41400893 |
113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41114236 |
114 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40860743 |
115 | Pertussis_Homo sapiens_hsa05133 | 0.39784279 |
116 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39754477 |
117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.37638231 |
118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37305561 |
119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36472141 |
120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36385337 |
121 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36266990 |
122 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36093086 |
123 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31340943 |
124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30628917 |
125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30248221 |
126 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.30132686 |
127 | Malaria_Homo sapiens_hsa05144 | 0.27200621 |
128 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26875307 |
129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26867629 |
130 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.23987720 |
131 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.23827276 |
132 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.23335103 |
133 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.22741716 |
134 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21509067 |
135 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20633030 |
136 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20197112 |
137 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.18083745 |
138 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17592149 |
139 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17353627 |
140 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.17253007 |
141 | Influenza A_Homo sapiens_hsa05164 | 0.16235865 |
142 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12853204 |
143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.11269460 |